On August 3, 1983, Kawamatsu, Yutaka; Fujita, Takeshi published a patent.Recommanded Product: 37480-41-4 The title of the patent was Thiazolidine derivatives. And the patent contained the following:
Thiazolidinediones I (R = oxocyclohexyl, hydroxycyclohexyl, methyloxocyclohexyl, methylhydroxycyclohexyl) were prepared, and they exhibited antidiabetic activity. 4-(3-Hydroxy-1-methyl-1-cyclohexylmethoxy)-1-nitrobenzene was treated with H over Pd/C, the aniline analog obtained was diazotized and treated with CH2:CHCO2Me to yield a Me 3-phenylpropionate derivative, and the latter was heated with thiourea and NaOAc to give I (R = 3-hydroxy-1-methylcyclohexyl). The experimental process involved the reaction of Methyl 1-methyl-4-oxocyclohexanecarboxylate(cas: 37480-41-4).Recommanded Product: 37480-41-4
The Article related to thiazolidinedione cyclohexylmethoxybenzyl preparation hypoglycemic, cyclohexylmethoxybenzylthiazolidinedione preparation hypoglycemic, antidiabetic cyclohexylmethoxybenzylthiazolidinedione preparation and other aspects.Recommanded Product: 37480-41-4
Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics